Fuente: FierceBiotech Eli Lilly and AI-powered clinical-stage biotech Insilico Medicine have announced a back-loaded, $2.75 billion biobucks drug discovery collaboration that will extend the Big Pharma company’s access to Insilico’s AI engine to pursue novel therapeutics.